IGF-1DESdosage The IGF-1 DES (1-3) peptide is a truncated analogue of insulin-like growth factor 1 (IGF-1) that has garnered attention for its enhanced potency compared to its parent compound. This specific peptide, also known as Des(1-3)IGF-I, is characterized by the absence of the first three amino acids at the N-terminus of the IGF-1 molecule. This structural modification significantly impacts its biological activity, leading to a heightened ability to stimulate cellular processes like hypertrophy and proliferation, often reported as being around tenfold more potent than intact IGF-1. Understanding the nature of IGF-1 DES (1-3) peptide is crucial for appreciating its potential applications and the scientific research surrounding it.IGF-1(IGF-I, insulin-like growth factor-1 or somatomedin C) is a secreted factor that circulates in complex with IGFBP-3 or IGFBP-5 with ALS.
The enhanced potency of IGF-1 DES (1-3) stems directly from its truncated structure.IGF-1 LR3 in Aesthetic and Anti-Aging Medicine: Benefits and ... By removing the initial tripeptide (Gly-Pro-Glu), the peptide exhibits a reduced affinity for IGF-binding proteins (IGFBPs). IGFBPs typically act as circulating carriers for IGF-1, modulating its bioavailability and activity. When the binding affinity for these proteins is diminished, more free IGF-1 DES (1-3) is available to interact with its receptor, the IGF-1 receptor (IGF-1R), on target cellsViral insulin-like peptides activate human insulin and IGF-1 .... This increased availability of the active peptide amplifies its downstream signaling cascades, leading to more pronounced effects on cell growth and repairBuy onlineIGF 1-3 Peptidefrom ProteoGenix cat# PTX-OS-IGF 1-3-41. Shop among our wide range of Peptides available at highly competitive prices.. Scientific studies have demonstrated that this altered interaction with IGFBPs is a key factor in the peptide's significantly greater potency in stimulating cellular hypertrophy and proliferation in vitroInsulin Like Growth Factor-I Des (1-3), human recombinant ....
While both IGF-1 DES (1-3) and IGF-1 LR3 are modified analogues of IGF-1 designed for increased efficacy, they differ in their structural modifications and resulting properties. IGF-1 LR3, for instance, is a longer variant that also exhibits reduced binding to IGFBPs, thereby increasing its half-life and bioavailability. Unlike DES (1-3), which is truncated, LR3 involves specific amino acid substitutions. These differences can lead to distinct pharmacokinetic profiles and potentially varied biological effects. While both are explored for their growth-promoting capabilities, the specific advantages and disadvantages of each may depend on the intended application. Research into these analogues often involves comparative studies to elucidate their unique characteristics and optimize their use in various research or therapeutic contexts.Insulin-like growth factor 1 tripeptide, IGF-I (1-3)
The potent anabolic and regenerative properties attributed to IGF-1 DES (1-3) have led to its investigation across several fields. Its capacity to stimulate cell growth, proliferation, and differentiation makes it a subject of interest in areas related to tissue repair and regeneration. In aesthetic and anti-aging medicine, such peptides are explored for their potential to promote cellular rejuvenation and improve tissue integrity. Furthermore, the peptide's impact on cellular metabolism and growth has led to its examination in contexts related to muscle growth and recovery, particularly in research settings. While not FDA-approved for general human use, its properties are a subject of ongoing scientific inquiry.
Interestingly, des(1-3)IGF-1 is not solely a synthetic modification; it is also a naturally occurring, endogenous protein found in biological systems. It has been isolated from sources such as bovine colostrumIGF-1 LR3 in Aesthetic and Anti-Aging Medicine: Benefits .... The recombinant human IGF-I/IGF-1 DES (1-3) protein is often produced in laboratory settings, typically using EIGF-I (1-3). coli as a host for expression. This recombinant production allows for controlled synthesis and purification of the peptide for research purposes. Understanding its natural presence alongside its engineered forms provides a more comprehensive view of its biological role.This N-terminal tripeptide ofIGF-I facilitated the in vitro release of acetylcholine with a several hundredfold higher potency.
Research into IGF-1 DES (1-3) and its analogues continues to explore its precise mechanisms of action and potential therapeutic benefits. Studies often focus on comparing the effects of different IGF-1 variants, including DES (1-3) and LR3, on various cellular pathways and physiological processes.IGF-I LR3is a recombinant analog of human IGF-I comprised of the complete IGF-I sequence, with an Arginine substitution for the third position Glutamic acid, ... The ability to block IGF-1 receptor signaling, for instance, is also an area of research, suggesting potential applications in understanding or modulating IGF-1 related conditions. As scientific understanding advances, the specific roles and applications of IGF-1 DES (1-3) peptide will become clearer, potentially opening new avenues for research and developmentIGF-1 LR3 is a potent growth-factor peptidethat drives muscle growth, enhances recovery, and supports cellular regeneration. It improves nutrient uptake, ....
Join the newsletter to receive news, updates, new products and freebies in your inbox.